Generic Name and Formulations:
Phenazopyridine HCl 95mg; tabs.
Personal Products Co.
Indications for URISTAT:
Urinary tract discomfort.
190mg 3 times daily after meals; max 2 days when used with antimicrobials.
Yellow discoloration of skin or sclera may indicate poor excretion. Stains soft contact lenses. Liver disease. Anemia. Discolors urine and fabric (red-orange). Elderly. Pregnancy. Nursing mothers.
Interferes with colorimetric urine tests.
Urinary tract analgesic.
GI upset, headache, rash, methemoglobinemia, hemolytic anemia, renal and hepatic toxicity.
Endocrinology Advisor Articles
- FDA Approves Admelog Short-Acting Insulin Lispro Injection
- Fertility Hormone Therapy and Cardiovascular Outcomes: What We Know
- Effects of Peer Influence in Adolescents With Type 1 Diabetes
- More Evidence That Saxagliptin Does Not Increase Risk for AMI in Diabetes
- One-Hour Glucose Readings Predict T2D Risk Better Than 2-Hour Measurements
- FDA: Vitamin B7 May Interfere With Lab Tests for Hormone Levels
- Injected and Oral Medications Equally Safe for Gestational Diabetes
- Adjunctive Dapagliflozin Improves Glycemic Control in T1D
- Estradiol Therapy May Benefit Overall Cognition in Postmenopausal Women
- Stopping Postmenopausal HT May Increase Risk for Cardiac, Stroke Death
- Psychosocial Benefits of a Bihormonal Bionic Pancreas System in T1D
- Safety of Chronic Total Occlusion Percutaneous Coronary Intervention in Diabetes
- Oral Insulin Not a Reliable Preventive Strategy for Type 1 Diabetes
- Prevention of Bone Mineral Density Loss Needed in Epilepsy
- Gastric Bypass Blunts B-Cell Sensitivity During Glycemia